DaVita HealthCare Partners Inc (DVA) · Peers
DaVita HealthCare Partners against the 13 other companies here in its SEC industry, Services-Misc Health & Allied Services, Nec. Each figure is the one on the company's own page; the median is the peers', and the rank is among all 14, highest first.
Measure by measure
| Measure | DVA | Peer median | Rank |
|---|---|---|---|
| Market value | $11.95B | median $225.59M | 1 of 13 |
| P/E | 14.1× | median 26.2× | 5 of 6 |
| Forward P/E | 12.6× | median 12.9× | 5 of 8 |
| EV/EBITDA | 7.8× | median 15.5× | 5 of 6 |
| P/S | 0.9× | median 2.1× | 11 of 13 |
| FCF yield | 13.5% | median 2.2% | 2 of 12 |
| Operating margin | 15.2% | median -0.5% | 1 of 10 |
| Net margin | 6.0% | median 2.8% | 4 of 11 |
| ROIC | 18.0% | median 6.4% | 2 of 6 |
| Revenue growth (4y, yearly) | 4.1% | median 6.2% | 8 of 10 |
| EPS growth (yearly) | 2.5% | median 1.2% | 3 of 6 |
| Current ratio | 1.5× | median 1.9× | 8 of 13 |
| Stock pay / revenue | 0.9% | median 3.0% | 9 of 14 |
| Share count change | -13.1% | median 0.5% | 10 of 10 |
Green where DaVita HealthCare Partners is on the better side of the median, red where on the worse; no colour where higher is neither, like size or dividend yield.
The peers, largest first
| Company | Market value | P/E | ROIC | Score |
|---|---|---|---|---|
| DVADaVita HealthCare Partners Inc | $11.95B | P/E 14.1× | 18.0% | 6.0 |
| FMSFresenius Medical Care AG | $11.80B | P/E – | – | 5.3 |
| SHCSotera Health Co | $5.11B | P/E 31.2× | – | 4.8 |
| PGNYProgyny, Inc. | $2.06B | P/E 26.2× | 40.9% | 6.9 |
| AGLagilon health, inc. | $1.43B | P/E – | – | 4.4 |
| MCTACharming Medical Ltd | $474.08M | P/E – | – | 3.1 |
| VMDViemed Healthcare Inc | $361.08M | P/E 24.9× | 12.8% | 6.1 |
| PARKPark Dental Partners, Inc. | $90.11M | P/E 94.0× | – | 5.2 |
| MRAIMarpai, Inc. | $83.98M | P/E – | – | 2.4 |
| BRTXBioRestorative Therapies, Inc. | $39.24M | P/E – | – | 3.6 |
| CCELCryo Cell International Inc | $35.64M | P/E – | – | 5.1 |
| PFHOPacific Health Care Organization Inc | $12.03M | P/E 12.3× | 6.4% | 5.5 |
| MGRXMangoceuticals, Inc. | $6.25M | P/E – | -77.3% | 3.3 |
| NIVFNewGenIvf Group Ltd | – | P/E – | -32.4% | 5.5 |
The industry is the Standard Industrial Classification code the company registered with the SEC. It is a broad label: a peer group is a starting point for comparing, not proof that two businesses are alike. None of this is advice.